Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Suzhou

Suzhou, ChinaNot linked to an institution yet

1running trial
0closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

No trial has been confirmed here yet.

Running trials

Active, not recruiting
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
NCT04076059· Phase 3· Source

Researchers

No researcher is linked here yet.

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error